Information for Informed Investment Decisions
Verastem Oncology, Inc. (NASDAQ: VSTM), is a biopharmaceutical company headquartered in Needham, MA. The focus of our research is developing a portfolio of novel small molecule drugs that inhibit critical RAS signaling pathways that promote cancer cell survival and tumor growth.
To learn more about our research program, as well as the details of our financials, please download the investor kits below. Verastem Oncology is a member of NASDAQ Biotechnology Index.
Well Positioned to Capitalize on Growth Opportunities
Corporate Latest 10-K
Annual Report for the Fiscal Year Ending December 31, 2022
Corporate Proxy Statement
Proxy Statement for Annual Meeting of Stockholders Held May 15, 2023